Recurrent Lung Cancer
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Alpha Radiation Emitters Device (DaRT) for the Treatment of Recurrent Lung Cancer (NCT05632913) | Alpha Tau Medical LTD. | 2023-07-01 |
| Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies (NCT05786924) | Institut de Recherches Internationales Servier | 2023-04-18 |
| A Phase 1/2 Trial of Trametinib and Erlotinib in Patients With EGFR-Mutant Lung Adenocarcinomas and Acquired Resistance to Erlotinib (NCT03076164) | Memorial Sloan Kettering Cancer Center | 2017-03-01 |
Track Recurrent Lung Cancer automatically
Every clearance here is in the API, with alerts when new ones post.